Aqueous Solubility and pH-Solubility Profile

Aqueous solubility is the equilibrium concentration a drug reaches in water, and the pH-solubility profile describes how that concentration changes across the physiological pH range for ionizable drugs. Because dissolution must precede absorption, solubility is among the most consequential preformulation properties and a frequent rate-limiter for poorly water-soluble candidates.

Definition

Aqueous solubility is the maximum amount of a drug that dissolves in water at equilibrium under defined conditions; the pH-solubility profile is the relationship between that equilibrium solubility and solution pH for an ionizable compound, governed by its intrinsic solubility and ionization constant.

Scope

The entry covers intrinsic solubility, the influence of ionization (pKa) on the solubility-pH curve through the Henderson-Hasselbalch relationship, the distinction between thermodynamic equilibrium and kinetic solubility, common measurement approaches such as the shake-flask and potentiometric methods, and the role of solubility within the Biopharmaceutics Classification System. It is reference content, not a dissolution-testing protocol.

Core questions

• How does ionization (pKa) shape the solubility of a drug across physiological pH?
• What distinguishes thermodynamic equilibrium solubility from kinetic solubility, and why does it matter?
• How does aqueous solubility, together with permeability, classify a drug under the Biopharmaceutics Classification System?

Key concepts

• Intrinsic solubility
• Ionization constant (pKa)
• pH-solubility profile
• Henderson-Hasselbalch relationship
• Thermodynamic versus kinetic solubility
• Shake-flask and potentiometric methods
• Biopharmaceutics Classification System (BCS)

Mechanisms

For an ionizable drug, total aqueous solubility is the sum of the dissolved un-ionized species (the intrinsic solubility, fixed by lattice energy and solvation) and the far more soluble ionized species, whose fraction is set by pH relative to the pKa. The pH-solubility profile therefore rises steeply on the side of pH that favours ionization and plateaus where the un-ionized form dominates, a behaviour described by the Henderson-Hasselbalch relationship. Equilibrium (thermodynamic) solubility reflects the stable solid form, whereas kinetic solubility can transiently exceed it from a metastable or amorphous state. Because only dissolved drug can permeate, solubility joins permeability to define a compound's Biopharmaceutics Classification System class and to flag dissolution-limited absorption.

Clinical relevance

Poor aqueous solubility is a leading reason that otherwise promising molecules show low or variable oral bioavailability, and solubility data inform whether formulation enhancement is needed. This entry explains how solubility governs drug behaviour for reference and educational purposes and is not guidance for prescribing or individualized therapy.

Evidence & guidelines

The Biopharmaceutics Classification System of Amidon et al. (1995) provides the regulatory-recognized framework relating solubility and permeability to in vivo performance and underpins solubility-based biowaiver guidance. Methodological standards for measuring solubility-pH profiles are set out by Avdeef et al. (2000), and the developability implications of low solubility are framed by Lipinski et al. (2001).

History

Quantitative treatment of drug solubility matured through the late twentieth century as poorly soluble candidates proliferated. Amidon et al. (1995) embedded solubility in a formal classification of oral drug behaviour, Lipinski et al. (2001) highlighted solubility as a developability filter, and refined potentiometric methods (Avdeef et al., 2000) made accurate solubility-pH profiling routine.

Key figures

• Gordon L. Amidon
• Alex Avdeef
• Christopher A. Lipinski

Seminal works

• amidon-1995
• lipinski-2001
• avdeef-2000

Frequently asked questions

Why does the solubility of a drug change with pH?

For ionizable drugs the ionized form is much more soluble than the un-ionized form, so as pH shifts to favour ionization the total solubility rises; the relationship is described by the drug's pKa and the Henderson-Hasselbalch equation.

What is the difference between thermodynamic and kinetic solubility?

Thermodynamic (equilibrium) solubility reflects the stable solid form at equilibrium, while kinetic solubility is a transient, often higher value measured before equilibrium, sometimes from a metastable or amorphous solid.